Covid vaccine is not a shot in the arm for all investors
‘There are certain sectors where the long-term viability is in question’
Coronavirus
-
-
How can European SMEs recapitalise after packing on the debt?
What alternative funding options could come into play?
-
Green bond issuance set to double by 2023 after hitting $1trn
Taking a fixed income approach to turn the crisis into a growth opportunity
-
S&P Global predicts K-shaped recovery
Full credit bounce back expected to start from 2023
-
Is emerging Europe recovery on hold until a vaccine appears?
Stocks are cheap but they have lagged global equity rally
-
Going green to pay for covid-19
Governments applying an ESG lens to the recovery brings opportunities for investors
-
How to control liquidity risks during volatile times
Jean-Philippe Blua explains how the firm’s tools alerted the asset manager to precarious portfolio positions
-
Half of active equity fund managers outperformed in H1 2020
They beat out their rivals with roughly 70% average outperformance
-
Shift to multi-stakeholder model to spur sustainable bonds
As social bond issuance hits historic record of $33bn in Q2, up threefold
-
Is there an ESG silver lining to Covid?
Oil pressure and green deals add to building momentum
-
Distressed leveraged finance ratios hit 2011 high
As banking sector is largely exposed to leveraged loans and marginally to high yield bonds
-
How will global value chain disruption fallout affect trade?
Renationalisation of chains likely a longer-term process, say observers